Takeda Pharmaceutical Company Limited Stock BOERSE MUENCHEN
Equities
TKD
JP3463000004
Pharmaceuticals
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.04 EUR | +1.86% |
|
-3.59% | -8.85% |
11:02am | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
10:45am | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Sales 2024 | 4,264B 26.73B 24.91B 36.56B | Sales 2025 * | 4,281B 26.84B 25.01B 36.71B | Capitalization | 6,320B 39.62B 36.92B 54.19B |
---|---|---|---|---|---|
Net income 2024 | 144B 903M 842M 1.24B | Net income 2025 * | 92.57B 580M 541M 794M | EV / Sales 2024 | 2.57 x |
Net Debt 2024 | 4,386B 27.5B 25.62B 37.61B | Net Debt 2025 * | 4,189B 26.26B 24.47B 35.92B | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
69.5
x | Employees | - |
Yield 2024 |
4.49% | Yield 2025 * |
4.84% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 week | -3.59% | ||
Current month | -3.32% | ||
1 month | -3.00% | ||
3 months | -11.48% | ||
6 months | -7.41% | ||
Current year | -8.85% |
![Extreme 23.5](/images/extremecours_fleche.png)
![Extreme 23.5](/images/extremecours_fleche.png)
![Extreme 23.4](/images/extremecours_fleche.png)
![Extreme 23.33](/images/extremecours_fleche.png)
![Extreme 23.33](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Date | Price | Change |
---|---|---|
24-06-24 | 24.04 | +1.86% |
24-06-21 | 23.6 | 0.00% |
24-06-20 | 23.6 | +0.43% |
24-06-19 | 23.5 | -1.38% |
24-06-18 | 23.83 | -3.40% |
Real-time BOERSE MUENCHEN, June 24, 2024 at 08:43 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.63% | 796B | |
+40.93% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.42% | 244B | |
+3.84% | 228B | |
+12.80% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock